[Federal Register Volume 62, Number 63 (Wednesday, April 2, 1997)]
[Notices]
[Page 15720]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-8301]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Division of Research Grants; Closed Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
Division of Research Grants Special Emphasis Panel (SEP) meetings:
Purpose/Agenda: To review individual grant applications.
Name of SEP: Biological and Physiological Sciences.
Date: April 10-12, 1997.
Time: 8 p.m.
Place: Westin Hotel, Waltham, MA.
Contact Person: Dr. David Remondini, Scientific Review
Administrator, 6701 Rockledge Drive, Room 6154, Bethesda, Maryland
20892, (301) 435-1038.
Name of SEP: Microbiological and Immunological Sciences.
Date: April 18, 1997.
Time: 8:30 a.m.
Place: NIH, Rockledge 2, Room 4186, Telephone Conference.
Contact Person: Dr. Gerald Liddel, Scientific Review
Administrator, 6701 Rockledge Drive, Room 4186, Bethesda, Maryland
20892, (301) 435-1150.
Name of SEP: Microbiological and Immunological Sciences.
Date: April 18, 1997.
Time: 1 p.m.
Place: NIH, Rockledge 2, Room 4186, Telephone Conference.
Contact Person: Dr. Gerald Liddel, Scientific Review
Administrator, 6701 Rockledge Drive, Room 4186, Bethesda, Maryland
20892, (301) 435-1150.
Purpose/Agenda: To Review Small Business Innovation Research.
Name of SEP: Biological and Physiological Sciences.
Date: April 4, 1997.
Time: 8:30 a.m.
Place: Doubletree Hotel, Rockville, MD.
Contact Person: Dr. Michael Micklin, Scientific Review
Administrator, 6701 Rockledge Drive, Room 5198, Bethesda, Maryland
20892, (301) 435-1258.
This notice is being published less than 15 days prior to the
above meetings due to the urgent need to meet timing limitations
imposed by the review and funding cycle.
The meetings will be closed in accordance with the provisions
set forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.
Applications and/or proposals and the discussions could reveal
confidential trade secrets or commercial property such as patentable
material and personal information concerning individuals associated
with the applications and/or proposals, the disclosure of which
would constitute a clearly unwarranted invasion of personal privacy.
(Catalog of Federal Domestic Assistance Program Nos. 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: March 27, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, National Institutes of Health.
[FR Doc. 97-8301 Filed 4-1-97; 8:45 am]
BILLING CODE 4410-01-M
